The human serum paraoxonase polymorphism: identification of phenotypes by their response to salts.
about
Reconsideration of the catalytic center and mechanism of mammalian paraoxonase/arylesteraseDistinction between 'A'-esterases and arylesterases. Implications for esterase classificationParaoxonases as potential antibiofilm agents: their relationship with quorum-sensing signals in Gram-negative bacteriaParaoxonase 1 activities and polymorphisms in autism spectrum disordersThe relationship between metabolic presbycusis and serum paraoxonase/arylesterase activityEvaluation of serum paraoxonase and arylesterase activities in ankylosing spondylitis patientsAnti-cyclic citrullinated peptide antibodies and paraoxonase-1 polymorphism in rheumatoid arthritis.Molecular basis for the polymorphic forms of human serum paraoxonase/arylesterase: glutamine or arginine at position 191, for the respective A or B allozymes.Paraoxon hydrolysis in human serum mediated by a genetically variable arylesterase and albuminDistribution profile of paraoxonase phenotypes among the Gujaratis.The human serum paraoxonase/arylesterase polymorphism.Role of genetic polymorphism of human plasma paraoxonase/arylesterase in hydrolysis of the insecticide metabolites chlorpyrifos oxon and paraoxon.Serum paraoxonase activity is decreased in the active stage of Behçet's disease.Oxidant/antioxidant status, paraoxonase activity, and lipid profile in plasma of ovariectomized rats under the influence of estrogen, estrogen combined with progesterone, and genistein.Addressing the link between paraoxonase-1 gene variants and the incidence of early onset myocardial infarction.Dynamic changes of paraoxonase 1 activity towards paroxon and phenyl acetate during coronary artery surgery.Serum arylesterase and paraoxonase activity in patients with chronic hepatitis.Higher serum lipids and oxidative stress in patients with normal tension glaucoma, but not pseudoexfoliative glaucoma.Human paraoxonase 1 hydrolysis of nanomolar chlorpyrifos-oxon concentrations is unaffected by phenotype or Q192R genotype.Prognostic value of paraoxonase 1 in patients undergoing coronary artery bypass grafting surgery.Therapeutic effects of thymoquinone in a model of neuropathic pain.Protective effects of ginseng extracts and common anti-aggregant drugs on ischaemia-reperfusion injury.A homogeneous cell-based assay for measurement of endogenous paraoxonase 1 activity.Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase.PPARs in Regulation of Paraoxonases: Control of Oxidative Stress and Inflammation Pathways.Paraoxonase is reduced in patients with growth hormone deficiency: A novel risk factor for atherosclerosis.Bis(4,4'-dimethyl-2,2'-bipyridine)oxidovanadium(IV) Sulfate Dehydrate: Potential Candidate for Controlling Lipid Metabolism?Aronia melanocarpa treatment and antioxidant status in selected tissues in Wistar rats.Ameliorating effects of CAPE on oxidative damage caused by pneumoperitoneum in rat lung tissue.Quantification of human serum paraoxonase by enzyme-linked immunoassay: population differences in protein concentrations.The neuroprotective effect of cornus MAS on brain tissue of Wistar rats.Genotype and phenotype of salt-stimulated paraoxonase 1 (PON1) is associated with atherogenic indices in type 2 diabetes
P2860
Q24322715-A0458AFD-2229-4A4F-B011-89D0111B6E40Q24529497-366E1717-F7F9-40DE-AB9D-42E41E13D1E5Q28302221-362C53C8-9F77-4FC4-97C8-189A0C75B7D8Q28390802-D6FA5975-5EF2-4FF0-BD3D-5118E2B55DBAQ30421787-B146E828-98AC-4418-A090-78E887674F6DQ33684694-BCB8450A-D672-44E0-BF37-E3BF15D93E0DQ34586496-CE25C0F3-F367-490E-AF78-DA5D3923F026Q35194393-B69A59B4-3269-45CC-8129-BA73442EB9D5Q35199852-51165123-2227-462D-A79A-61EFEE645587Q35199882-4B34824B-32CA-49B5-A7CA-F242031A7451Q35203636-F2DCB8DC-7E43-472A-AA0C-7D8B82700EF1Q35246950-818543EA-A8C0-40AE-BF50-FFB657F46BD1Q35592493-6234FA73-CB68-4E84-9A9E-3157D6059076Q35746794-575CAA3B-1977-4223-86E2-732571D73D8DQ35829214-3F6EFFC9-85AF-4329-AB48-D5AB3EF548E0Q36334425-D5E81246-D804-413A-B418-CF2D1EF28921Q36497033-E9B9DABD-23DA-4F0C-B037-5D2429551C6DQ36614210-29733672-5D9D-4085-A6C9-CAE42D4331AFQ36755360-B75F2486-E623-45ED-AC23-1EDE683B2987Q37707993-B20402D3-D72B-43CB-944C-884FECB0188DQ37715512-8880446E-6173-4ACC-BDC1-96552298A6A9Q38804326-4440A7A9-837A-4F64-AFC4-0BEBAE81A106Q39748960-7FBB592E-98C9-4713-AEDA-A45F36A49369Q39802300-1165DE45-0E2E-4A71-BFA6-BD8FD9712BF6Q40793611-C668FEB7-AB68-4202-9BD5-E0E558891703Q41854438-49312603-57B2-4A34-A552-C4A59C847C54Q42259783-8FF08FF6-3151-44CC-B04A-4179E8CF55B5Q42736657-336CEF98-A1FC-4103-BCCE-5264528C1A1DQ42789492-AEC1F1F6-EF2B-4273-A9BD-8919F6490B55Q42830683-38550A42-F402-41ED-B899-54076C127FE7Q55430906-F0F80490-E0A0-45B9-B4A8-B398EEBFAC32Q57147406-85187696-075B-465B-A331-82683D897B7A
P2860
The human serum paraoxonase polymorphism: identification of phenotypes by their response to salts.
description
1983 nî lūn-bûn
@nan
1983 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1983 թվականի մարտին հրատարակված գիտական հոդված
@hy
1983年の論文
@ja
1983年学术文章
@wuu
1983年学术文章
@zh-cn
1983年学术文章
@zh-hans
1983年学术文章
@zh-my
1983年学术文章
@zh-sg
1983年學術文章
@yue
name
The human serum paraoxonase po ...... es by their response to salts.
@ast
The human serum paraoxonase po ...... es by their response to salts.
@en
type
label
The human serum paraoxonase po ...... es by their response to salts.
@ast
The human serum paraoxonase po ...... es by their response to salts.
@en
prefLabel
The human serum paraoxonase po ...... es by their response to salts.
@ast
The human serum paraoxonase po ...... es by their response to salts.
@en
P2093
P2860
P1476
The human serum paraoxonase po ...... pes by their response to salts
@en
P2093
P2860
P304
P407
P577
1983-03-01T00:00:00Z